WUTIF Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Mesentech Inc.mesentech.comMar 2022
Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration.
BiotechHealthtechVancouver
Barbara Yanni(Director)Samuel Wu(Director)David Hyman(Executive Officer)Robert Norman Young(Executive Officer, Director)Jay Mohr(Director)David Dvorak(Director)
PartnerMike Volker· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.